Inventor · disambiguated record
Naim Nazef
Also filed as: NAZEF NAIM
5 granted patents·4 pending applications·7 citations·filing 2017–2025
71Inventor score
Top patents by PatentIndex Score
9 records- 0193US11661604B2Methods and compositions for inhibiting expression of LDHADICERNA PHARMACEUTICALS INC·Filed 2020·Granted May 30, 2023·3 cites·20 claims
- 0286US11414659B24'-phosphate analogs and oligonucleotides comprising the sameDICERNA PHARMACEUTICALS INC·Filed 2017·Granted Aug 16, 2022·3 cites·44 claims
- 0380US11286488B2Methods and compositions for inhibiting expression of LDHADICERNA PHARMACEUTICALS INC·Filed 2018·Granted Mar 29, 2022·1 cites·25 claims
- 0479US2025283091A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2025·Application pending·0 cites
- 0577US2024182901A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2022·Application pending·0 cites
- 0670US12037586B24′-phosphate analogs and oligonucleotides comprising the sameDICERNA PHARMACEUTICALS INC·Filed 2022·Granted Jul 16, 2024·0 cites·26 claims
- 0752US2022389430A1Chemical modifications of small interfering rna with minimal fluorine contentDICEMA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0849US11873488B2Double-stranded nucleic acid inhibitor molecules modified with Tm-increasing nucleotidesDICERNA PHARMACEUTICALS INC·Filed 2019·Granted Jan 16, 2024·0 cites·36 claims
- 0949US2022306679A1Ligand-2'-modified nucleic acids, synthesis thereof and intermediate compounds thereofDICERNA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naim Nazef files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →